InvestorsHub Logo
Followers 62
Posts 2098
Boards Moderated 0
Alias Born 05/09/2020

Re: Borel Fields post# 91476

Tuesday, 07/07/2020 3:31:04 AM

Tuesday, July 07, 2020 3:31:04 AM

Post# of 233118
Borel,

Judging just by volume that Samsung claims to produce, not counting setup/breakdown/maintenance time, they can roughly produce 1,000L per day.

CytoDyn has contracted to have 2.5M doses produced in 2021.

2.5M doses = 7000L

So, Samsung Biologics can theoretically produce enough Leronlimab to make 2.5M doses in about one week. ...and that generates $9B of revenue at the end of the supply chain ??

One week's work ? I know there's a lot more to it than that...but hey.



I haven't looked at AGC Biologics closely, but they have some formidable production capabilities also.

http://www.agcbio.com/capabilities/cgmp_manufacturing/
http://www.agcbio.com/resources/casestudies/antibodyproduction
https://www.agc.com/en/news/detail/1200761_2814.html


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News